RFK Jr: NIH Scientists Profit from Drugs They Approve—'We'll Slash Royalties to $1'

RFK Jr: "NIH scientists who work on the development of new drugs can individually collect royalties [of $150,000 per drug] on those drugs forever."

"So you have scientists whose job it is to find problems with these products, and instead they have this enormous economic incentive... not to find problems in that product."

"It puts agency capture on steroids. And as soon as we get a hold of NIH, we're going to reduce that $150,000 payment to $1."